Nicole Tilton

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study

Rolando M. Viani, Theodore Ruel, Carmelita Alvero, Terry Fenton et autres

BACKGROUND: P1093 is an ongoing phase I/II multicenter open-label study of dolutegravir plus an optimized background regimen in age-defined pediatric cohorts; here we report the long-term safety and virologic efficacy outcomes for the oldest cohort. METHODS: The study enrolled human immunodeficiency virus …

us (code pays fourni par la source)

Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US

Tristan T. Sands, Shahryar Rahdari, Michael S. Oldham, Eduardo Caminha Nunes et autres

us, be (code pays fourni par la source)

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman, Elizabeth A. Thiele et autres

us (code pays fourni par la source)

Ophthalmic manifestations of perinatally acquired HIV in a US cohort of long-term survivors: Table 1

Tina Rutar, Jiwon Youm, Travis C. Porco, Nicole Tilton et autres

BACKGROUND/AIMS: To determine the ophthalmic manifestations of HIV in a cohort of long-term survivors of perinatally acquired HIV. METHODS: Twenty-two patients with perinatally acquired HIV who were aged ≥12 years were prospectively studied at a university clinic. They underwent complete ophthalmic examinations …

us (code pays fourni par la source)